The global anatomic pathology market is projected to grow at an annual rate of almost 6% over the forecast time frame 2019 to 2026, according to Acumen Research and Consulting. The global based market intelligence company expects the market to reach a value of around $24 billion by 2026. The report provides analysis of global Anatomic Pathology market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.
The specialty of Anatomic Pathology is a medical science speciality linked to the diagnosis of different tissues and organ, using microscopic, macroscopic, immunological, biochemical or molecular exams. Operational pathology has unbelievably progressed from the primitive autopsy technique to a modernized approach over many years. It also focuses on diagnostic cancer and oncological forecasts, which help in decision-making and act as a guide in decision-making. The worldwide anatomical pathological market is pushing rapid growth of cancer, such as breast cancer, pulmonary cancer and colorectal cancer.
Download Free Sample Report Pages for Better Understanding, Download Here
Technology is expected to boost the adoption rate of sophisticated anatomical pathological devices in tools and protocols used during anatomical pathology. The integration of healthcare informatics norms by improving effectiveness and reducing expenses is a driving factor for the industry. Market actors cooperate in pathology laboratory renovation with the incorporation of innovative models for diagnosing diseases. This in turn speeds up investments in pathological machinery upgrading.
Thermo Fisher and Leica Microsystems worked together in April 2018 to develop an integrated workflow for studying cryo-tomography. Within the framework of this partnership, the businesses combined their current technology to provide improved microscopic alternatives that are user friendly and reliable, allowing scientists to obtain insights into biological procedures.
The anatomical pathology market is supported by pathology-trainee programs provided by government and private bodies to pathologists. Some of the associations which started various training programs and exams for the evaluation of a pathologist’s skill and understanding are the Royal College of Pathologists and the General Medical Council and the Association of Anatomical Pathology Technology.
The Diagnostics Laboratories segment is anticipated to achieve the fastest growth rate with technological developments in tools to minimize the danger of mistakes by integrating novel designs.
The dominant income share of the consumables has been ascribed to high availability, low costs and frequent buy rates of consumables such as reagents and samples.
The scholarly study sector has been driven by the increased application of anatomical pathology processes in studies like tumor examination and biomarker profiling.
The shift from standard to custom medicine has led to the fastest growth of the drug discovery and development sector. This is mainly because findings of alleged biomarkers are increasingly being relied upon to develop personalisation.
The biggest share of hospitals has been contributed by increasing hospitalization rates which stimulates the implementation of pathological workflows for disease monitoring and diagnosis.
On the other side, the development of the diagnostic lab segment is enhanced by the use of advanced laboratory devices and instruments, various electronic interfaces and IT systems.
In addition to a big amount of government financing programs, the presence of important players like Thermo Fisher and Agilent contributes to the biggest proportion in North America.
Asia Pacific is anticipated to show the highest development in the industry of anatomic pathology driven by the existence of numerous organizations involved in pathology practice.
The diagnosis of multiple infectious diseases, multiple cancer types as well as medical circumstances involves anatomical pathology by examining tissues and cells samples from the biopsy report. Increasingly aging, chronic illnesses are on the rise, and expensive healthcare are all showing favorable development in this industry. This has recently improved the need for the market for anatomic pathology. In the coming years, the nations with the highest amount of older populations will develop the market for anatomical pathology. Technological advances will also function as the driving force for this industry in the healthcare industry.
Key Players & Strategies
Some of the key players are Laboratory Corporation of America Holdings; Thermo Fisher Scientific, Inc.; Sakura Finetek USA, Inc. Cardinal Health, Inc.; Agilent Technologies, Inc.; F. Hoffmann-La Roche AG; Quest Diagnostics Incorporated; BioGenex; NeoGenomics Laboratories, Inc.; and Bio SB.
These main players implement various approaches in order to retain their important market share during the forecast period. Collaborative development, corporate development and product development are the strategies introduced.
For instance, in June 2018, Agilent Technologies introduced a range of probes, such as MALT1, MYC, BCL6, BCL2, CCND1, IGH, IGH / BCL2, IGH / MYC, and IGH /CCND1, for in situ hybridization. The launch of these products has improved the portfolio of the company and thus reinforced its place in the industry.
Market, By Product and Service
- Reagents & Antibodies
- Probes & Kits
- Tissue processors
- Automatic Stainers
- Microtomes & Cryostat
Market, By Application
- Drug Discovery & Development
- Disease Diagnosis
Market, By End-use
- Diagnostic Laboratories
- Research Laboratories
Market, By Geography
- North America.
- Latin America
- Middle East and Africa (MEA)
The market research study on “Anatomic Pathology Market – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026” offers detailed insights on global Anatomic Pathology market segments with market dynamics and their impact. The report also covers basic technology development policies.
It offers an assessment of the recent industry trends for each sub-segment between 2015 and 2026, and anticipates income development at worldwide, regional and nation levels. For this research, ARC segmented the worldwide Anatomic Pathology market report on the grounds various segments.
Contact Here, email@example.com | +1 407 915 4157 OR +1 408 900 9135
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1525
About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.